Correlation Between Estrella Immunopharma and Ipsos SA

Can any of the company-specific risk be diversified away by investing in both Estrella Immunopharma and Ipsos SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Estrella Immunopharma and Ipsos SA into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Estrella Immunopharma and Ipsos SA, you can compare the effects of market volatilities on Estrella Immunopharma and Ipsos SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Estrella Immunopharma with a short position of Ipsos SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Estrella Immunopharma and Ipsos SA.

Diversification Opportunities for Estrella Immunopharma and Ipsos SA

0.12

Correlation Coefficient

Estrella Immunopharma  Ipsos SA

Average diversification

The 3 months correlation between Estrella and Ipsos is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Estrella Immunopharma and Ipsos SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ipsos SA and Estrella Immunopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Estrella Immunopharma are associated (or correlated) with Ipsos SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ipsos SA has no effect on the direction of Estrella Immunopharma i.e., Estrella Immunopharma and Ipsos SA go up and down completely randomly.

Pair Corralation between Estrella Immunopharma and Ipsos SA

Assuming the 90 days horizon Estrella Immunopharma is expected to generate 5.46 times more return on investment than Ipsos SA. However, Estrella Immunopharma is 5.46 times more volatile than Ipsos SA. It trades about 0.05 of its potential returns per unit of risk. Ipsos SA is currently generating about -0.09 per unit of risk. If you would invest  8.79  in Estrella Immunopharma on December 29, 2024 and sell it today you would lose (1.08) from holding Estrella Immunopharma or give up 12.29% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	53.85%
Values	Daily Returns

Estrella Immunopharma  vs.  Ipsos SA

Estrella Immunopharma

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Estrella Immunopharma are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Estrella Immunopharma showed solid returns over the last few months and may actually be approaching a breakup point.

Ipsos SA

Risk-Adjusted Performance

Very Weak

Over the last 90 days Ipsos SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Estrella Immunopharma and Ipsos SA

The main advantage of trading using opposite Estrella Immunopharma and Ipsos SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Estrella Immunopharma position performs unexpectedly, Ipsos SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ipsos SA will offset losses from the drop in Ipsos SA's long position.

The idea behind Estrella Immunopharma and Ipsos SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.